These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 19536194)

  • 21. Foxp3-deficient regulatory T cells do not revert into conventional effector CD4+ T cells but constitute a unique cell subset.
    Kuczma M; Podolsky R; Garge N; Daniely D; Pacholczyk R; Ignatowicz L; Kraj P
    J Immunol; 2009 Sep; 183(6):3731-41. PubMed ID: 19710455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory T cell identity: formation and maintenance.
    Li X; Zheng Y
    Trends Immunol; 2015 Jun; 36(6):344-53. PubMed ID: 25981968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kickstarting Foxp3 with c-Rel.
    Hsieh CS
    Immunity; 2009 Dec; 31(6):852-3. PubMed ID: 20064443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional stability of Foxp3+ regulatory T cells.
    da Silva Martins M; Piccirillo CA
    Trends Mol Med; 2012 Aug; 18(8):454-62. PubMed ID: 22771168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth.
    Manrique SZ; Correa MA; Hoelzinger DB; Dominguez AL; Mirza N; Lin HH; Stein-Streilein J; Gordon S; Lustgarten J
    J Exp Med; 2011 Jul; 208(7):1485-99. PubMed ID: 21670203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of human FoxP3
    Attias M; Al-Aubodah T; Piccirillo CA
    Clin Exp Immunol; 2019 Jul; 197(1):36-51. PubMed ID: 30864147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic changes in E-protein activity regulate T reg cell development.
    Gao P; Han X; Zhang Q; Yang Z; Fuss IJ; Myers TG; Gardina PJ; Zhang F; Strober W
    J Exp Med; 2014 Dec; 211(13):2651-68. PubMed ID: 25488982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes.
    Ono M
    Immunology; 2020 May; 160(1):24-37. PubMed ID: 32022254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YY1 inhibits differentiation and function of regulatory T cells by blocking Foxp3 expression and activity.
    Hwang SS; Jang SW; Kim MK; Kim LK; Kim BS; Kim HS; Kim K; Lee W; Flavell RA; Lee GR
    Nat Commun; 2016 Feb; 7():10789. PubMed ID: 26892542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.
    Obermajer N; Popp FC; Soeder Y; Haarer J; Geissler EK; Schlitt HJ; Dahlke MH
    J Immunol; 2014 Nov; 193(10):4988-99. PubMed ID: 25305313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular mechanisms of Foxp3 gene regulation.
    Maruyama T; Konkel JE; Zamarron BF; Chen W
    Semin Immunol; 2011 Dec; 23(6):418-23. PubMed ID: 21752667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.
    Maynard CL; Harrington LE; Janowski KM; Oliver JR; Zindl CL; Rudensky AY; Weaver CT
    Nat Immunol; 2007 Sep; 8(9):931-41. PubMed ID: 17694059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental plasticity of Foxp3+ regulatory T cells.
    Hori S
    Curr Opin Immunol; 2010 Oct; 22(5):575-82. PubMed ID: 20829012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-β signaling controls
    Sun X; Cui Y; Feng H; Liu H; Liu X
    J Exp Med; 2019 Dec; 216(12):2819-2837. PubMed ID: 31515281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and maintenance of regulatory T cells.
    Ohkura N; Kitagawa Y; Sakaguchi S
    Immunity; 2013 Mar; 38(3):414-23. PubMed ID: 23521883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sox12 promotes T reg differentiation in the periphery during colitis.
    Tanaka S; Suto A; Iwamoto T; Kageyama T; Tamachi T; Takatori H; Suzuki K; Hirose K; Ohara O; Lefebvre V; Nakajima H
    J Exp Med; 2018 Oct; 215(10):2509-2519. PubMed ID: 30190287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Foxp3 expression in T regulatory cells and other cell lineages.
    Devaud C; Darcy PK; Kershaw MH
    Cancer Immunol Immunother; 2014 Sep; 63(9):869-76. PubMed ID: 25063364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional regulation of Foxp3 in regulatory T cells.
    Haiqi H; Yong Z; Yi L
    Immunobiology; 2011 Jun; 216(6):678-85. PubMed ID: 21122941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory T Cells: the Many Faces of Foxp3.
    Georgiev P; Charbonnier LM; Chatila TA
    J Clin Immunol; 2019 Oct; 39(7):623-640. PubMed ID: 31478130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells.
    Rudra D; Egawa T; Chong MM; Treuting P; Littman DR; Rudensky AY
    Nat Immunol; 2009 Nov; 10(11):1170-7. PubMed ID: 19767756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.